DRUG

MKT CAP:$851M

Bright Minds Biosciences Inc

Market Cap

$851M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$69.00-$14.46 (-17.33%)

Jun 5, 2026

52W High $95.9852W Low $23.27

Company Details

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists...

CEO

—

IPO Date

Mar 22, 2021

Website

brightmindsbio.com

Key Metrics TTM (CAD)

Revenue

CAD 0

- YoY

Net Income

-CAD 28M

EPS (Diluted)

Free Cash Flow

-CAD 20M

Revenue / Share

CAD 0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q3 2026

Aug 13, 2026

PENDING

Q2 2026

May 20, 2026

CAD 0

Q1 2026

Feb 13, 2026

CAD 0

FY 2025

Dec 23, 2025

CAD 0

Q4 2025

Dec 23, 2025

CAD 0

Revenue & Profitability (CAD)

Operating Cash Flow (CAD)

CapEx Spend (CAD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CAD)

OpEx Breakdown (CAD)

War Chest (CAD)

Shares Outstanding

Revenue Per Employee (CAD)

Revenue / Employee